Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy.
D002746:Chlorpromazine / Q000008:administration & dosage* / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008548:Melanosis / Q000139:chemically induced* / Q000188:drug therapy; D010396:Penicillamine / Q000627:therapeutic use; D010546:Perphenazine / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use
D014268:Trifluoperazine; D010546:Perphenazine; D010396:Penicillamine; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine